ArticleACS omega2021
Cr(VI)-Mediated Homogeneous Fenton Oxidation for Decolorization of Methylene Blue Dye: Sludge Free and Pertinent to a Wide pH Range.
Article in ACS omega, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 38 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fe(II)-mediated Fenton process is commonly employed for oxidative degradation of recalcitrant pollutants in wastewater. However, the method suffers from limitations like narrow working pH range and iron sludge formation. The present work deals with the degradation of Methylene Blue (MB) dye using Fenton-like oxidation by replacing Fe(II) with Cr(VI), which eliminates the limitations of classical Fenton oxidation. The Fenton-like oxidation of MB is brought about by HO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.